Autopsy report · NCT00181649

Recombinant Human Prolactin for Lactation Induction

“Not able to recruit any subjects.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Massachusetts General Hospital

Sponsor type

University, hospital or other

Conditions

Lactation

Interventions

Recombinant human prolactin

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity
  “Not able to recruit subjects” (94% match in meaning)
• Repaglinide for Adolescents With Cystic Fibrosis-Related Diabetes
  “Unable to recruit any subjects” (93% match in meaning)
• Prospective Evaluation of Symptom Resolution in Acid Versus Non-acid Reflux Disease Following Anti-reflux Surgery
  “Unable to recruit a sufficient number of subjects.” (89% match in meaning)
• A Pilot and Feasibility Study of Fecal Microbiota Transplantation for Ulcerative Colitis
  “Unable to recruit and enroll eligible subjects.” (86% match in meaning)
• FDG Uptake and Lung Blood Flow in PAH Before and After Treatment With Ambrisentan
  “inability to recruit subjects” (85% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.